Fibromyalgia affects millions of people worldwide, causing persistent widespread pain, debilitating fatigue, sleep disturbances, and cognitive difficulties that significantly impact quality of life. When traditional treatments like medications, physical therapy, and lifestyle modifications haven’t provided adequate relief, transcranial magnetic stimulation (TMS) offers an investigational approach targeting the neurological mechanisms underlying chronic pain. At Complete Mind Care of PA, our team of over 20 board-certified providers brings expertise from building a 35-location TMS practice, positioning us to offer advanced neuromodulation protocols for fibromyalgia within appropriate clinical frameworks.
Our leadership team’s experience building Success TMS to 35 locations provides extensive knowledge of TMS protocols for chronic pain conditions. This expertise informs our approach to targeting the neural circuits involved in pain processing, mood regulation, and sleep disturbance that characterize fibromyalgia.
We exclusively use BrainsWay Deep TMS, which penetrates deeper brain structures than traditional figure-8 coils. This deeper reach allows us to effectively target the prefrontal cortex regions involved in pain modulation, as well as networks connecting to the limbic system and other areas that process pain signals and regulate pain perception.
Fibromyalgia requires multi-modal treatment addressing pain, sleep, mood, and function. Our multi-disciplinary team integrates TMS with therapy, medication management when appropriate, lifestyle optimization, and other evidence-based interventions to support comprehensive symptom relief and improved quality of life.
With three suburban Philadelphia locations in Horsham, Villanova, and Newtown Square, plus extended hours from 7 AM to 8 PM on weekdays, we make it easier to incorporate treatment into your schedule despite the fatigue and pain limitations of fibromyalgia. We serve more than 4,500 active patients and accept 50+ insurance plans.
Fibromyalgia is a complex chronic pain condition characterized by widespread musculoskeletal pain, profound fatigue, sleep disturbances, and a constellation of other symptoms that vary between individuals. The condition affects an estimated 4 million adults in the United States, with women diagnosed approximately twice as often as men.
Chronic Widespread Pain: The hallmark of fibromyalgia is persistent pain affecting multiple areas of the body, typically including muscles, joints, and soft tissues. The pain is often described as a constant dull ache that has persisted for at least three months. Many people with fibromyalgia also experience tender points—specific locations on the body that are particularly sensitive to pressure and touch.
Profound Fatigue: Extreme tiredness that doesn’t improve with rest is a defining feature of fibromyalgia. This fatigue can be so severe that it interferes with work, social activities, and basic daily tasks. Many people describe feeling exhausted even after a full night’s sleep, as though their bodies never fully rest or recover.
Sleep Disturbances: Fibromyalgia frequently disrupts normal sleep architecture, causing difficulty falling asleep, frequent nighttime awakenings, and non-restorative sleep. Many individuals wake feeling unrefreshed regardless of time spent in bed. Sleep disorders like restless leg syndrome and sleep apnea occur at higher rates in people with fibromyalgia, further compromising sleep quality.
Cognitive Difficulties (“Fibro Fog”): Problems with memory, concentration, attention, and mental clarity—often called “fibro fog”—significantly impact many people with fibromyalgia. This cognitive dysfunction can affect work performance, make it difficult to follow conversations or complete tasks, and contribute to feelings of frustration and diminished capability.
Mood Disorders: Depression and anxiety occur at substantially higher rates in individuals with fibromyalgia compared to the general population. The relationship is bidirectional—chronic pain and functional limitations contribute to mood problems, while depression and anxiety can amplify pain perception and worsen other fibromyalgia symptoms.
Additional Symptoms: Many people with fibromyalgia experience headaches, temporomandibular joint disorders (TMJ), irritable bowel syndrome, sensitivity to temperature and noise, numbness or tingling in extremities, and heightened sensitivity to pain throughout the body (central sensitization).
Fibromyalgia presents significant treatment challenges because its exact cause remains incompletely understood and symptoms vary substantially between individuals. Current research indicates that fibromyalgia involves abnormal pain processing in the central nervous system, with the brain and spinal cord amplifying pain signals in a process called central sensitization. The condition appears to result from a combination of genetic factors, physical or emotional trauma, infections, and other triggers that alter how the nervous system processes pain.
Traditional treatment approaches often provide only partial symptom relief. Medications approved for fibromyalgia—including pregabalin, duloxetine, and milnacipran—help some patients but frequently cause side effects and don’t fully resolve symptoms. Physical therapy, exercise programs, and cognitive behavioral therapy offer benefits but require sustained effort that can be difficult to maintain given fatigue and pain levels. Many people with fibromyalgia try multiple treatments over years while continuing to experience significant symptom burden and functional impairment.
Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique that uses focused magnetic fields to modulate neural activity in specific brain regions. While TMS received FDA clearance for treatment-resistant depression and OCD, researchers have explored its application for chronic pain conditions including fibromyalgia based on understanding of the neural circuits involved in pain processing and perception.
The rationale for using TMS in fibromyalgia stems from neuroimaging studies showing altered activity in brain regions responsible for pain modulation. The dorsolateral prefrontal cortex and motor cortex, both accessible to TMS, play important roles in how the brain processes and regulates pain signals. By stimulating these regions, TMS may help normalize pain processing circuits and reduce the amplification of pain signals characteristic of fibromyalgia.
The BrainsWay Deep TMS system we use employs H-Coil technology that reaches deeper brain structures than traditional TMS coils. During treatment, you sit comfortably while we position the TMS helmet on your head. The system delivers brief magnetic pulses that pass painlessly through the scalp and skull to stimulate underlying brain tissue.
Modulating Pain Processing Networks: TMS targets the dorsolateral prefrontal cortex, a region involved in top-down modulation of pain perception. Stimulating this area may strengthen the brain’s ability to down-regulate pain signals and reduce the amplification of sensory input that occurs in fibromyalgia. The effects extend through connections to other pain-processing regions including the anterior cingulate cortex, insula, and thalamus.
Addressing Mood and Sleep: Because the prefrontal cortex also regulates mood and connects to sleep-wake circuits, TMS stimulation may help address the depression, anxiety, and sleep disturbances that frequently accompany and worsen fibromyalgia pain. Improvements in mood and sleep quality can create positive feedback loops that further reduce pain perception and improve overall function.
Promoting Neuroplasticity: Repeated TMS sessions induce lasting changes in neural activity patterns through neuroplastic mechanisms. These changes may help the brain develop healthier patterns of pain processing that persist beyond the treatment period, potentially providing sustained symptom relief.
Your journey begins with comprehensive evaluation by one of our board-certified providers. We review your fibromyalgia diagnosis, symptom history, previous treatments tried, current medications, and overall health status. We assess pain levels, functional limitations, mood symptoms, sleep quality, and cognitive function using standardized measures. We discuss whether investigational TMS protocols for fibromyalgia align with your situation, review the research basis and limitations, and answer all your questions about the treatment process.
If TMS appears appropriate, we develop a personalized stimulation protocol based on your specific symptom profile. This includes determining optimal target locations (typically dorsolateral prefrontal cortex or motor cortex), stimulation parameters (frequency, intensity, duration), and treatment schedule. Protocols for fibromyalgia typically involve daily or near-daily sessions over 4-6 weeks, with each session lasting 20-40 minutes.
Before beginning treatment, we perform detailed brain mapping to ensure accurate targeting of the intended cortical regions. This involves measuring your head anatomy and using neuroanatomical landmarks to identify the optimal coil position. Precise targeting is essential for effectively modulating the pain processing networks we’re seeking to influence.
During each session, you sit in a comfortable treatment chair while the Deep TMS helmet is positioned on your head. You remain fully alert and awake throughout treatment. The magnetic pulses create a tapping sensation on your scalp and produce clicking sounds. Most people adjust to these sensations quickly. Because treatment is non-invasive with minimal systemic effects, you can drive yourself to and from appointments and return immediately to your daily activities.
We systematically track changes in your fibromyalgia symptoms throughout treatment using pain scales, functional assessments, sleep quality measures, mood questionnaires, and reports of real-world symptom changes. This monitoring helps us assess treatment response and determine whether any protocol adjustments might optimize outcomes. Many patients notice gradual improvements in specific symptoms before experiencing overall pain reduction.
TMS works best as part of comprehensive fibromyalgia management rather than as standalone treatment. We coordinate with your other providers and may recommend continuing or adjusting medications, engaging in physical therapy or gentle exercise programs, practicing good sleep hygiene, and utilizing stress management techniques. This multi-modal approach addresses fibromyalgia’s multiple dimensions and supports sustained improvement.
Important Note: TMS for fibromyalgia remains an investigational application not FDA-approved for this specific indication. Research continues to evolve, and individual results vary significantly.
Reduced Pain Intensity: Many patients experience meaningful reductions in overall pain levels and the severity of painful episodes, allowing improved function and engagement in daily activities.
Decreased Fatigue: By addressing neurological factors contributing to fatigue and improving sleep quality, TMS may help reduce the profound tiredness that limits function in fibromyalgia.
Improved Sleep Quality: Modulation of prefrontal circuits involved in sleep regulation may lead to better sleep architecture, fewer nighttime awakenings, and more restorative rest.
Enhanced Mood and Reduced Anxiety: Given TMS’s established efficacy for depression, treating the prefrontal cortex can simultaneously address both pain and the mood disturbances common in fibromyalgia.
Cognitive Improvements: Some patients report reduced “fibro fog” and improved mental clarity, concentration, and memory function following TMS treatment.
Better Functional Capacity: Reductions in pain and fatigue, combined with improvements in mood and sleep, often translate to enhanced ability to work, exercise, socialize, and perform daily tasks.
Non-Invasive with Minimal Side Effects: Unlike pain medications that can cause significant systemic side effects, TMS is non-invasive, doesn’t require daily dosing, and produces minimal adverse effects beyond temporary scalp discomfort.
Potential for Long-Lasting Effects: Unlike medications that require continuous use, TMS may produce lasting changes in pain processing that persist after treatment ends, though maintenance sessions may be needed.
Investigational Use: TMS for fibromyalgia represents investigational off-label use not approved by the FDA. While research supports potential benefits, this application remains experimental and outcomes are not guaranteed. Treatment decisions should be made with full understanding of the investigational nature and current evidence limitations.
Individual Variability: Response to TMS for fibromyalgia varies significantly between individuals. While many people experience meaningful symptom improvement, others show minimal or no benefit despite completing a full treatment course. Factors influencing response are not fully understood, making it difficult to predict who will benefit most.
Not a Cure: TMS does not cure fibromyalgia. It’s a symptom management tool that may reduce pain, improve function, and enhance quality of life, but fibromyalgia remains a chronic condition requiring ongoing management. TMS should be viewed as one component of comprehensive treatment rather than a standalone cure.
Cost Considerations: If insurance doesn’t cover TMS for fibromyalgia, treatment requires cash payment. Given the investigational nature and variable outcomes, carefully consider the financial investment relative to potential but uncertain benefits. We provide transparent pricing information during consultation.
Comprehensive Approach Needed: TMS works best as part of multi-modal fibromyalgia management. Continuing appropriate medications, engaging in gentle exercise or physical therapy, practicing good sleep hygiene, managing stress, and addressing comorbid conditions all support optimal outcomes. TMS alone, without attention to other aspects of fibromyalgia management, is less likely to produce substantial lasting benefit.
Time and Commitment: TMS protocols typically require daily or near-daily sessions over 4-6 weeks. This represents a significant time commitment that can be challenging for people with fibromyalgia fatigue and functional limitations. Consider whether you can realistically maintain this schedule before beginning treatment.
If you’ve been struggling with fibromyalgia pain, fatigue, and functional limitations despite trying medications, therapy, and lifestyle modifications, investigational TMS protocols may offer a path toward improved symptom control and quality of life. Our team brings extensive neuromodulation expertise and a comprehensive approach to pain management that goes beyond simply chasing symptom reduction.
Ready to explore whether TMS could help your fibromyalgia?
Contact Complete Mind Care of PA today to schedule your consultation. We’ll evaluate your symptoms, review your treatment history, discuss whether investigational TMS protocols align with your situation, and answer all your questions about this advanced approach to fibromyalgia management.
No. TMS received FDA clearance for treatment-resistant depression and OCD, but not for fibromyalgia or chronic pain conditions. TMS for fibromyalgia represents investigational off-label use based on research findings but without regulatory approval for this specific indication.
Insurance coverage for investigational applications varies. Most insurance companies cover TMS only for FDA-approved indications meeting medical necessity criteria. Coverage for fibromyalgia would depend on your specific plan, whether you have comorbid depression that meets coverage criteria, and whether your insurer considers investigational treatments. Our team will verify your coverage and discuss payment options during consultation.
Individual responses vary significantly. Research suggests that approximately 75% of fibromyalgia patients experience some degree of symptom improvement with TMS, with pain reductions typically ranging from 30-50% in responders. However, some people experience minimal or no benefit, while others achieve more substantial relief. Realistic expectations are important given the investigational nature of this application.
Duration of benefit varies considerably between individuals. Some patients maintain improvements for months following treatment, while others experience gradual return of symptoms. Maintenance TMS sessions may help sustain benefits, though optimal maintenance protocols remain under investigation. Long-term outcomes require further research.
TMS is not painful, though you’ll feel tapping sensations on your scalp where the magnetic pulses are delivered. Some people experience mild scalp discomfort or headache during the first few sessions, but this typically resolves quickly. Treatment requires no anesthesia and allows you to remain fully alert.
In most cases, yes. TMS can be safely combined with fibromyalgia medications including pregabalin, duloxetine, gabapentin, and pain relievers. We’ll review all your medications during consultation. Some patients eventually reduce medications as symptoms improve, though medication changes should always be made in collaboration with your prescribing physician.
Many people with fibromyalgia experience comorbid depression or anxiety. TMS can address both pain and mood symptoms simultaneously by targeting prefrontal regions involved in both conditions. In fact, having depression alongside fibromyalgia may make you more likely to experience benefit from TMS, as the treatment has established efficacy for mood disorders.
TMS offers a different mechanism than medication, physical therapy, or behavioral approaches. It may be particularly valuable for people who haven’t found adequate relief from traditional treatments or who experience significant medication side effects. Many patients achieve best results combining TMS with other evidence-based fibromyalgia management approaches rather than relying on TMS alone.
TMS is generally safe with few side effects. The most common side effects are temporary scalp discomfort and mild headache. Serious side effects like seizure are very rare. TMS is contraindicated for people with certain metal implants near the head (pacemakers, cochlear implants, deep brain stimulators), as magnetic fields can interfere with these devices. We carefully screen for contraindications during evaluation.
Important: The information on this page describes investigational use of TMS technology for fibromyalgia, an application not approved by the FDA or other regulatory agencies. While research suggests potential benefits for fibromyalgia pain and associated symptoms, TMS for this indication remains experimental. Individual outcomes vary significantly, and symptom improvement is not guaranteed. Some patients experience meaningful relief while others show minimal or no response to treatment.
This information is for educational purposes only and does not constitute medical advice or a recommendation for treatment. All decisions regarding investigational TMS protocols should be made in consultation with qualified healthcare providers after thorough discussion of potential benefits, significant limitations, risks, alternative treatments, and realistic expectations. Insurance may not cover investigational applications, potentially requiring cash payment.
TMS for fibromyalgia should be viewed as one potential component of comprehensive pain management rather than a standalone solution. Continue working with your rheumatologist, pain specialist, or primary care provider to address all aspects of fibromyalgia care.
Remission is our mission. Let us help you explore advanced approaches to managing fibromyalgia and reclaiming your quality of life.
Conditions Treated
721 Dresher Rd # 1100, Horsham, PA 19044
Complete Mind Care was founded on the premise of providing full mental health support delivered by a team of expert professionals, in the comfort of a world-class facility local to you—so you can build a foundation for lasting recovery close to home. Plus 40+ additional insurance carriers accepted.
Don’t see your insurance listed? Call our office at 215-607-7250 or 215-918-7939 to verify coverage.
